Identification of serologically silent occult hepatitis C virus infection by detecting immunoglobulin G antibody to a dominant HCV core peptide epitope

Journal of Hepatology

Volumn 50, Issue 2, 2009, Pages 256-263

  Quiroga, Juan A ^a   Castillo, Inmaculada ^a   Llorente, Silvia ^a   Bartolomé, Javier ^a   Barril, Guillermina ^a,b   Carreño, Vicente ^a  

^a Fundacion para el Estudio de Las Hepatitis Virales   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Hepatitis C virus (HCV); IgG anti HCVcore testing; Serological diagnosis; Serologically silent occult HCV infection

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; EPITOPE; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PEPTIDE; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; LIVER BIOPSY; LIVER CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION; SEROLOGY; STATISTICAL SIGNIFICANCE; VIRUS IDENTIFICATION;

ADULT; ANTIBODY SPECIFICITY; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; VIRAL CORE PROTEINS;

EID: 58149299825     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.08.021     Document Type: Article

References (40)

1. Alter H.J., and Seeff L.B. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis 20 (2000) 17-35
2. Strader D.B., Wright T., Thomas D.L., and Seeff L.B. American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C. Hepatology 39 (2004) 1147-1171
3. Pham T.N., MacParland S.A., Mulrooney P.M., Cooksley H., Naoumov N.V., and Michalak T.I. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 78 (2004) 5867-5874
4. Radkowski M., Gallegos-Orozco J.F., Jablonska J., Colby T.V., Walewska-Zielecka B., Kubicka J., et al. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 41 (2005) 106-114
5. Castillo I., Rodríguez-Iñigo E., López-Alcorocho J.M., Pardo M., Bartolomé J., and Carreño V. Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment. Clin Infect Dis 43 (2006) 1277-1283
6. Castillo I., Pardo M., Bartolomé J., Ortiz-Movilla N., Rodríguez-Iñigo E., de Lucas S., et al. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 189 (2004) 7-14
7. Schmidt W.N., Wu P., Cederna J., Mitros F.A., LaBrecque D.R., and Stapleton J.T. Surreptitious hepatitis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and negative HCV antibody tests. J Infect Dis 176 (1997) 27-33
8. Alter M.J., Kuhnert W.L., and Finelli L. Centers for Disease Control and Prevention. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Morb Mortal Wkly Rep Recomm Rep 52 (2003) 1-13
9. Quiroga J.A., Castillo I., Bartolomé J., and Carreño V. Serum immunoglobulin G antibodies to the GOR autoepitope are present in patients with occult hepatitis C virus (HCV) infection despite lack of HCV-specific antibodies. Clin Vaccine Immunol 14 (2007) 1302-1306
10. Mishiro S., Takeda K., Hoshi Y., Yoshikawa A., Gotanda T., and Itoh Y. An autoantibody cross-reactive to hepatitis C virus core and a host nuclear antigen. Autoimmunity 10 (1991) 269-273
11. Chen M., Sällberg M., Sönnerborg A., Weiland O., Mattsson L., Jin L., et al. Limited humoral immunity in hepatitis C virus infection. Gastroenterology 116 (1999) 35-143
12. Ching W.M., Wychowski C., Beach M.J., Wang H., Davies C.L., Carl M., et al. Interaction of immune sera with synthetic peptides corresponding to the structural protein region of hepatitis C virus. Proc Natl Acad Sci USA 89 (1992) 3190-3194
13. Sällberg M., Rudén U., Wahren B., and Magnius L.O. Immunodominant regions within the hepatitis C virus core and putative matrix proteins. J Clin Microbiol 30 (1992) 1989-1994
14. Lechmann M., Ihlenfeldt H.G., Braunschweiger I., Giers G., Jung G., Matz B., et al. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus - positive blood donors without viremia. Hepatology 24 (1996) 790-795
15. Okamoto H., Tsuda F., Machida A., Munekata E., Akahane Y., Sugai Y., et al. Antibodies against synthetic oligopeptides deduced from the putative core gene for the diagnosis of hepatitis virus infection. Hepatology 15 (1992) 180-186
16. Bartolomé J., López-Alcorocho J.M., Castillo I., Rodríguez-Iñigo E., Quiroga J.A., Palacios R., et al. Ultracentrifugation of serum samples allows detection of hepatitis C virus RNA in patients with occult hepatitis C. J Virol 81 (2007) 7710-7715
17. Scheuer P.J. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13 (1991) 372-374
18. Quiroga J.A., Pardo M., Navas S., Martín J., and Carreño V. Patterns of immune responses to the host-encoded GOR and hepatitis C virus core-derived epitopes with relation to hepatitis C viremia, genotypes, and liver disease severity. J Infect Dis 173 (1996) 300-305
19. Sällberg M., Rudén U., Wahren B., and Magnius L.O. Immune response to a single peptide containing an immunodominant region of hepatitis C virus core protein: the isotypes and the recognition site. Immunol Lett 33 (1992) 27-33
20. Sato A., Sho Y., Nakamura H., Kunitomo T., and Arima T. Immune responses of blood donors to peptides of various lengths and those with genotypic sequence variations corresponding to the N-terminal portion of the core protein of hepatitis C virus. J Med Virol 44 (1994) 88-91
21. Sällberg M., Pumpen P., Zhang Z.X., Lundholm P., Gusars I., Rudén U., et al. Locations of antibody binding sites within conserved regions of the hepatitis C virus core protein. J Med Virol 43 (1994) 62-68
22. Ishida C., Matsumoto K., Fukada K., Matsushita K., Shiraki H., and Maeda Y. Detection of antibodies to hepatitis C virus (HCV) structural proteins in anti-HCV-positive sera by an enzyme-linked immunosorbent assay using synthetic peptides as antigens. J Clin Microbiol 31 (1993) 936-940
23. Netski D.M., Mosbruger T., Depla E., Maertens G., Ray S.C., Hamilton R.G., et al. Humoral immune response in acute hepatitis C virus infection. Clin Infect Dis 41 (2005) 667-675
24. Muerhoff A.S., Gutierrez R., Kyrk C., Leary T., Schlauder G., Dawson G., et al. Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies. J Med Virol 80 (2008) 411-418
25. Beld M., Penning M., van Putten M., van den Hoek A., Damen M., Klein M.R., et al. Low levels of hepatitis C virus RNA in serum, plasma, and peripheral blood mononuclear cells of injecting drug users during long antibody-undetectable periods before seroconversion. Blood 94 (1999) 1183-1191
26. Takaki A., Wiese M., Maertens G., Depla E., Seifert U., Liebetrau A., et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 6 (2000) 578-582
27. Toyoda H., Kumada T., Kiriyama S., Sone Y., Tanikawa M., Hisanaga Y., et al. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy. Clin Infect Dis 40 (2005) 49-54
28. Umemura T., Wang R.Y., Schechterly C., Shih J.W., Kiyosawa K., and Alter H.J. Quantitative analysis of anti-hepatitis C virus antibody-secreting B cells in patients with chronic hepatitis C. Hepatology 43 (2006) 91-99
29. Pham T.N.Q., King D., Macparland S.A., McGrath J.S., Reddy S.B., Bursey F.R., et al. Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection. Gastroenterology 134 (2008) 812-822
30. Rehermann B., Seifert U., Tillmann H.L., Michel G., Böker K.H., Pichlmayr R., et al. Serological pattern of hepatitis C virus recurrence after liver transplantation. J Hepatol 24 (1996) 15-20
31. Ando Y., Sönnerborg A., Barkholt L., Birkett A., Ericzon B.G., and Sällberg M. Antibody production against hepatitis C virus core and nonstructural 3 proteins is highly sensitive to deficits in T-cell function. Clin Diagn Lab Immunol 4 (1997) 104-106
32. Post J.J., Pan Y., Freeman A.J., Harvey C.E., White P.A., Palladinetti P., et al. Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort. J Infect Dis 189 (2004) 1846-1855
33. Quiroga J.A., Castillo I., Pardo M., Rodríguez-Iñigo E., and Carreño V. Combined hepatitis C virus (HCV) antigen-antibody detection assay does not improve diagnosis for seronegative individuals with occult HCV infection. J Clin Microbiol 44 (2006) 4559-4560
34. Semmo N., Barnes E., Taylor C., Kurtz J., Harcourt G., Smith N., et al. T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors. Lancet 365 (2005) 327-329
35. Pawlotsky J.M., Bastie A., Pellet C., Remire J., Darthuy F., Wolfe L., et al. Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay. J Clin Microbiol 34 (1996) 80-83
36. Zein N.N., Germer J.J., Wendt N.K., Schimek C.M., Thorvilson J.N., Mitchell P.S., et al. Indeterminate results of the second-generation hepatitis C virus (HCV) recombinant immunoblot assay: significance of high-level c22-3 reactivity and influence of HCV genotypes. J Clin Microbiol 35 (1997) 311-312
37. Kondili L.A., Chionne P., Costantino A., Villano U., Lo Noce C., Pannozzo F., et al. Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut 50 (2002) 693-696
38. Lefrère J.J., Girot R., Lefrère F., Guillaume N., Lerable J., Le Marrec N., et al. Complete or partial seroreversion in immunocompetent individuals after self-limited HCV infection: consequences for transfusion. Transfusion 44 (2004) 343-348
39. Quiroga J.A., Llorente S., Castillo I., Rodríguez-Iñigo E., Pardo M., and Carreño V. Cellular immune responses associated with occult hepatitis C virus infection of the liver. J Virol 80 (2006) 10792-10799
40. Shata M.T., Tricoche N., Perkus M., Tom D., Brotman B., McCormack P., et al. Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees. Virology 314 (2003) 601-616